Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients
Background The non-invasive biomarkers for predicting immunotherapy response are urgently needed to prevent both premature cessation of treatment and ineffective extension. This study aimed to construct a non-invasive model for predicting immunotherapy response, based on the integration of deep lear...
Gespeichert in:
Veröffentlicht in: | Cancer Immunology, Immunotherapy : CII Immunotherapy : CII, 2024-06, Vol.73 (8), p.153, Article 153 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
The non-invasive biomarkers for predicting immunotherapy response are urgently needed to prevent both premature cessation of treatment and ineffective extension. This study aimed to construct a non-invasive model for predicting immunotherapy response, based on the integration of deep learning and habitat radiomics in patients with advanced non-small cell lung cancer (NSCLC).
Methods
Independent patient cohorts from three medical centers were enrolled for training (
n
= 164) and test (
n
= 82). Habitat imaging radiomics features were derived from sub-regions clustered from individual’s tumor by K-means method. The deep learning features were extracted based on 3D ResNet algorithm. Pearson correlation coefficient,
T
test and least absolute shrinkage and selection operator regression were used to select features. Support vector machine was applied to implement deep learning and habitat radiomics, respectively. Then, a combination model was developed integrating both sources of data.
Results
The combination model obtained a strong well-performance, achieving area under receiver operating characteristics curve of 0.865 (95% CI 0.772–0.931). The model significantly discerned high and low-risk patients, and exhibited a significant benefit in the clinical use.
Conclusion
The integration of deep-leaning and habitat radiomics contributed to predicting response to immunotherapy in patients with NSCLC. The developed integration model may be used as potential tool for individual immunotherapy management. |
---|---|
ISSN: | 1432-0851 0340-7004 1432-0851 |
DOI: | 10.1007/s00262-024-03724-3 |